✦ LIBER ✦

Present status of BCG immunotherapy of malignant melanoma

✍ Scribed by D. L. Morton; F. R. Eilber; E. C. Holmes; F. C. Sparks; K. P. Ramming

Publisher: Springer-Verlag
Year: 1976
Tongue: English
Weight: 628 KB
Volume: 1-1
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf00205300

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BCG immunotherapy for recurrent malignan

BCG immunotherapy for recurrent malignant melanoma

✍ Shelley L. Rasmussen; Jordan U. Gutterman; Evan M. Hersh; Sydney Boston; M. Mars 📂 Article 📅 1980 🏛 Springer-Verlag 🌐 English ⚖ 789 KB

A study was made of immunologic parameters obtained from patients with stage IIIB malignant melanoma who were treated with BCG. Patients with the longest disease-free interval and survival times were those who had small initial skin test reactions and developed larger reactions during the course of

Adjuvant immunotherapy with BCG in stage

Adjuvant immunotherapy with BCG in stage II malignant melanoma

✍ M. J. Byrne; G. van Hazel; P. M. Reynolds; W. M. Lemish; C. D. J. Holman 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract Forty‐one patients were treated with BCG immunotherapy following block dissection of lymph nodes involved with malignant melanoma. A control group of similar patients who received no immunotherapy was drawn from a population consisting of all patients with malignant melanoma diagnosed i

Corynebacterium parvum versus BCG adjuva

Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma

✍ Allan Lipton; Harold A. Harvey; Bellarmine Lawrence; Robert Gottlieb; Miodrag Ku 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 1 views

Immunologic function during adjuvant BCG

Immunologic function during adjuvant BCG immunotherapy for malignant melanoma: Induction of anergy

✍ A. S. Coates; R. G. Klopp; J. M. Zarling; E. C. Borden; J. J. Crowley; P. P. Car 📂 Article 📅 1979 🏛 Springer-Verlag 🌐 English ⚖ 456 KB

Serial tests of immunological function were performed on 28 patients participating in a randomized controlled clinical trial of adjuvant Tice-stain BCG immunotherapy administered by tine technique for malignant melanoma. Cryopreserved lymphocyte samples obtained prior to study entry and at 3 and 6 m

Adjuvant immunotherapy of malignant mela

Adjuvant immunotherapy of malignant melanoma

✍ Gerard V. Aranha; Charles F. McKhann; Theodor B. Grage; Audolfur Gunnarsson; Ric 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

BCG in the immunotherapy of malignant ly

BCG in the immunotherapy of malignant lymphomas

✍ B. Hœrni; J. Chauvergne; G. Hœrni-Simon; M. Durand; C. Lagarde 📂 Article 📅 1977 🏛 Springer-Verlag 🌐 English ⚖ 326 KB